HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics

StatusActive, Not Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study completion pushed from Jun 15, 2026 to Oct 1, 2026v16
  2. Study completion date: Dec 31, 2025 to Jun 15, 2026v15
  3. Results first posted: Dec 11, 2025
    • Secondary endpoint revised
    • Primary endpoint revised
    v14
  4. Study completion date: Mar 31, 2025 to Dec 31, 2025v13
  5. Primary completion date changed from estimate of Dec 30, 2024 to Aug 14, 2024
    • Study completion date: Dec 30, 2024 to Mar 31, 2025
    v12
Show 10 earlier versionsHide 10 earlier versions
  1. Primary and study completion dates: Jun 30, 2024 to Dec 30, 2024v11
  2. Re-verified, no change to tracked fieldsv10
  3. Primary and study completion dates pushed to Jun 30, 2024
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 435 to confirmed 465
    • Site details revised
    v9
  4. Primary completion date: Jul 31, 2023 to Dec 31, 2023v8
  5. Primary completion date: Dec 28, 2023 to Jul 31, 2023
    • Study completion date: Dec 31, 2024 to Mar 31, 2024
    v7
  6. Primary completion date: Feb 28, 2023 to Dec 28, 2023
    • Study completion date: Mar 31, 2024 to Dec 31, 2024
    v6
  7. Study completion date: Feb 28, 2023 to Mar 31, 2024v5
  8. Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: Jun 15, 2023 to Feb 28, 2023
    • Start date changed from estimate of Dec 15, 2021 to Dec 30, 2021
    • Site details revised
    v4
  9. Start date: Oct 15, 2021 to Dec 15, 2021v3
  10. Start date: Jun 15, 2021 to Oct 15, 2021v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
City of Hope Medical Center
425 trials monitored
See 55 trials at risk
Breast Cancer
5,486 trials monitored
See 311 trials at risk
Lung Cancer
4,822 trials monitored
See 267 trials at risk
Colorectal Cancer
3,420 trials monitored
See 162 trials at risk
and 3 more diseases
This clinical trial studies the effectiveness of a web-based cancer education tool called Helping Oncology Patients Explore Genomics (HOPE-Genomics) in improving patient knowledge of personal genomic testing results and cancer and genomics in general. HOPE-Genomics is a web-based education tool that teaches cancer/leukemia patients, and patients who may be at high-risk for developing cancer, about genomic testing and provide patients with information about their own genomic test results. The HOPE-Genomics tool may improve patient's genomic knowledge and quality of patient-centered care. In addition, it may also improve education and care quality for future patients.
Trial Details
NCT Number NCT04905082
Lead Sponsor City of Hope Medical Center
Collaborators: National Cancer Institute (NCI)
Conditions
(from sponsor)		 Breast Carcinoma, Colorectal Carcinoma, Lung Carcinoma, Malignant Solid Neoplasm, Ovarian Carcinoma, Pancreatic Carcinoma, Prostate Carcinoma
Related terms Breast Neoplasms, Colorectal Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms
Enrollment 465 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov